Endometrial Cancer
Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA
Published in Cancer Weekly, October 21st, 2003
"Rapamycin exerts its biological activity by inhibiting the kinase mammalian target of rapamycin (mTOR), which regulates important cellular processes such as control of cell cycle and cell size, translation initiation, and transcription," researchers in the United States report.
"The ability of rapamycin to inhibit cancer cell proliferation has led to efforts to develop rapamycin and related mTOR inhibitors as anticancer agents. Some investigators have hypothesized that loss of the PTEN tumor suppressor may sensitize tumor cells to the anti proliferative activity of rapamycin...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-10-21)
More Articles from Cancer Weekly
- Cancer Therapy
Carboxyamido-triazole interrupts angiogenic stimulation to diminish tumor size - Melanoma
New way of examining lymph tissue detects hidden disease - Gene Imaging
Antisense gene imaging reveals breast cancer's response to therapy - Medulloblastoma
Beta-catenin transcriptional activation may be c-myc overexpression mechanism - Melanoma Therapy
Interleukin-12 needed for anti-metastatic effects of Z-100 - Neuroblastoma
Maternal folic acid intake linked to decrease in deadly childhood cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
